NCT00688883
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Nagoya, Aichi-ken, Japan
- Kashiwa-shi, Chiba, Japan
- Fukuoka, Japan
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,977 public trials
2,028 recruiting studies
Immunoproliferative Disorders trial results
Completed
Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL
NCT00311129
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Nagoya, Aichi-ken, Japan
- Kashiwa-shi, Chiba, Japan
- Isehara-shi, Kanagawa, Japan
NCT00003421
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
- Locations
-
- St. James's Hospital Leeds, England, United Kingdom
- Weston Park Hospital Sheffield, England, United Kingdom
NCT00220311
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
Not specified
NCT00344825
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- Many Locations, Italy
Completed
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
NCT01129180
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +35 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00985959
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Fukuoka, Japan
- Hiroshima, Japan
- Hitachi, Japan
- Isehara, Japan
NCT01697020
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Parexel International, Bloemfontein Early Phase Clinical Unit Bloemfontein, South Africa
NCT01998503
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +9 more
- Locations
-
- Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China
Completed
Velcade in MALT Lymphoma Patients
NCT00373906
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
Not specified